Beta Blockers as Primary and Secondary Prevention for Aortic Dissections in Nonsyndromic Patients With Hypertension
Beta blocker use did not reduce AD risk or improve outcomes in survivors of AD compared with other antihypertensive agents. Although clinically relevant data as aortic diameters and blood pressure were not available, these findings challenge current clinical practice and highlight the need for randomized trials.
Authors
- Oke Gerke (ORCID: https://orcid.org/0000-0001-6335-3303)
- Katrine Lawaetz Kristensen (ORCID: https://orcid.org/0000-0002-6234-5181)
- Amalie Lambert Mørkved (ORCID: https://orcid.org/0000-0002-8914-8612)
- Axel Cosmus Pyndt Diederichsen (ORCID: https://orcid.org/0000-0002-1285-4826)
- Joachim Sejr Skovbo (ORCID: https://orcid.org/0000-0001-6108-0153)
- Reshaabi Srinanthalogen
- Leila Louise Benhassen (ORCID: https://orcid.org/0000-0003-1298-0299)
- Mads Liisberg (ORCID: https://orcid.org/0000-0002-5275-4176)
- Lasse M. Obel (ORCID: https://orcid.org/0000-0003-0037-8962)
- Jes S. Lindholt (ORCID: https://orcid.org/0000-0001-9536-4488)
- Henrik Kjærulf Jensen (ORCID: https://orcid.org/0000-0003-1802-4302)
- Jesper Hallas (ORCID: https://orcid.org/0000-0002-8097-8708)
- Anne N. Lasota (ORCID: https://orcid.org/0000-0001-6489-3213)
Institutions
- University of Southern Denmark (DK)
- Aarhus University (DK)
- Aalborg University Hospital (DK)
- Odense University Hospital (DK)
- Aarhus University Hospital (DK)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1161/jaha.124.040149
- Citations
- 1
- Primary Topic
- Aortic Disease and Treatment Approaches
- Type
- article
- Field-Weighted Citation Impact
- 1.52